Literature DB >> 21676612

Discovery of a novel series of nonacidic benzofuran EP1 receptor antagonists.

Amanda C Allan1, Andy Billinton, Susan H Brown, Anita Chowdhury, Andrew J Eatherton, Charlotte Fieldhouse, Gerard M P Giblin, Paul Goldsmith, Adrian Hall, David N Hurst, Alan Naylor, D Anthony Rawlings, Mairi Sime, Tiziana Scoccitti, Pamela J Theobald.   

Abstract

We describe the discovery and optimization of a novel series of benzofuran EP(1) antagonists, leading to the identification of 26d, a novel nonacidic EP(1) antagonist which demonstrated efficacy in preclinical models of chronic inflammatory pain.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21676612     DOI: 10.1016/j.bmcl.2011.05.047

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

1.  Theoretical study of the regioselective cyclization of enaminones in the construction of benzofurans and indoles.

Authors:  Rafael Herrera; Francisco Méndez; Fabiola Jiménez; M Carmen Cruz; Joaquín Tamariz
Journal:  J Mol Model       Date:  2016-04-30       Impact factor: 1.810

2.  Development of an in vivo active, dual EP1 and EP3 selective antagonist based on a novel acyl sulfonamide bioisostere.

Authors:  Jason D Downey; Sam A Saleh; Thomas M Bridges; Ryan D Morrison; J Scott Daniels; Craig W Lindsley; Richard M Breyer
Journal:  Bioorg Med Chem Lett       Date:  2012-11-24       Impact factor: 2.823

3.  Total synthesis of panicein A2.

Authors:  Lili Yeung; Lisa I Pilkington; Melissa M Cadelis; Brent R Copp; David Barker
Journal:  Beilstein J Org Chem       Date:  2015-10-26       Impact factor: 2.883

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.